Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

Detalles Bibliográficos
Autores principales: de Velasco, Guillermo, Carril-Ajuria, Lucia, Guerrero-Ramos, Felix, Alonso-Gordoa, Teresa, Rodríguez-Moreno, Juan F., Carretero, Alberto, Martin-Soberon, Maricruz, de la Rosa-Kehrmann, Federico, Castellano, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Addendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359456/
https://www.ncbi.nlm.nih.gov/pubmed/36455393
http://dx.doi.org/10.18632/oncotarget.28263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359456/
https://www.ncbi.nlm.nih.gov/pubmed/36455393
http://dx.doi.org/10.18632/oncotarget.28263

Ejemplares similares